Fabio Cortellini

Scorrano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Journal: American journal of therapeutics

Published: July 23, 2026

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study.

Journal: American journal of therapeutics

Published: July 23, 2026

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study.

Journal: Advances in therapy

Published: February 11, 2026

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Journal: Journal of clinical medicine

Published: August 27, 2025

The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study.

The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study.

Journal: Nutrients

Published: July 23, 2025

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study.

Journal: Intestinal research

Published: April 29, 2025

Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey.

Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey.

Journal: Journal of clinical medicine

Published: January 11, 2025

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study.

Journal: Journal of clinical medicine

Published: September 23, 2024

Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.

Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Published: November 10, 2021

EUS-guided fine-needle biopsy for gastric submucosal tumors: Does one size fit all?

EUS-guided fine-needle biopsy for gastric submucosal tumors: Does one size fit all?

Journal: Endoscopic ultrasound

Published: November 10, 2021

Graded pneumatic dilation in subtype I and II achalasia: long-term experience in a single center.

Graded pneumatic dilation in subtype I and II achalasia: long-term experience in a single center.

Journal: Annals of gastroenterology

Published: July 11, 2021

Gastric Melanoma of Unknown Primary.

Gastric Melanoma of Unknown Primary.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: January 24, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026